Label | 2019-04-02 |
Letter | 2019-04-04 |
Review | 2019-07-12 |
Letter | 2021-07-19 |
Label | 2021-07-20 |
NDA 202408 | FERA PHARMS LLC |
Discontinued | 001 |
001 | OINTMENT;OPHTHALMIC | 3% | 1 | AVACLYR | ACYCLOVIR |
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2019-03-29 | STANDARD |
ORIG | 1 | Orphan | 5 |
cder:Array ( [0] => Array ( [ApplNo] => 202408 [companyName] => FERA PHARMS LLC [docInserts] => ["",""] [products] => [{"drugName":"AVACLYR","activeIngredients":"ACYCLOVIR","strength":"3% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"OINTMENT;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}] [labels] => [{"actionDate":"07\/16\/2021","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/202408s001lbl.pdf\"}]","notes":""},{"actionDate":"03\/29\/2019","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/0202408s000lbl.pdf\"}]","notes":""}] [originalApprovals] => [{"actionDate":"03\/29\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/0202408s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/202408Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2019\\\/202408Orig1s000TOC.cfm\"}]","notes":">"}] [supplements] => [{"actionDate":"07\/16\/2021","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/202408s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/202408Orig1s001ltr.pdf\"}]","notes":">"}] [actionDate] => 2021-07-16 ) )